MedTrace Logo

Role of PET/MRI in Head and Neck Cancer

NCT04360993 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 110

Last updated 2020-12-29

No results posted yet for this study

Summary

Study aim was to investigate the diagnostic role of Positron Emission Tomography / Magnetic Resonance Imaging (PET/MRI) in head and neck cancer.

Conditions

Interventions

RADIATION

Radiotherapy

Patients have received radiotherapy as a treatment modality for Head and neck cancer

Sponsors & Collaborators

  • University of Pecs

    lead OTHER

Principal Investigators

  • Arpad Kovacs, MD, PhD · University of Pecs

  • Cselik Zsolt, MD, PhD · Csolnoky Ferenc Kórház, Veszprém, Hungary

  • Omar Freihat · Doctoral school of health sciences, Pécs University, Hungary

Eligibility

Min Age
41 Years
Max Age
88 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-04-12
Primary Completion
2019-08-09
Completion
2020-01-22

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04360993 on ClinicalTrials.gov